Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 376Gynecologic 5Genitourinary 5Thoracic 4Sarcoma 3Other 3Head & Neck 2Gastrointestinal 2Endocrine 2Other solid neoplasm 1Lymphoid 1

Conditions

Obesity 3Breast Neoplasms 3Sexual Dysfunctions, Psychological 1Progesterone Resistance 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Arthralgia 1

Interventions

Exercise 9exemestane 4Psychiatric Rehabilitation 4Tamoxifen 3Methods 3Metformin 3Letrozole 3Early Intervention, Educational 3Diet Therapy 3Bupropion 3Bariatric Surgery 3Anastrozole 3Vitamin D 2Therapeutics 2Sugars 2Specimen Handling 2Naltrexone 2Mammography 2Diet, Mediterranean 2Counseling 2Cognitive Behavioral Therapy 2Cholecalciferol 2Blood Specimen Collection 2rosiglitazone-metformin combination 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Yoga 1Walking 1Tirzepatide 1Testosterone Propionate 1Testosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Letrozole × Other × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 3 Unknown
412 enrolled
BreastOther

Breast Neoplasms, Obesity

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

Completed
115 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡